Table 1. Abridged Period Life Table for Men and Women With Type 1 Diabetes vs General Population Without Type 1 Diabetes in Scotland 2008-2010.
| Age Interval, y | Observed Data in Type 1 Diabetes Population | Estimated Additional Life Expectancy, (95% CI), ya | ||||
|---|---|---|---|---|---|---|
| Observed Deaths | Population at Mid-age Intervalb | Death Rate per 1000 Person-Years | Type 1 Diabetes Population | General Population Without Type 1 Diabetesc | Difference in Life Expectancy, y | |
| Men | ||||||
| 20-24 | 10 | 1215 | 2.8 | 46.2 (45.3-47.3) | 57.3 (57.2-57.4) | 11.1 (10.1-12.1) |
| 25-29 | 12 | 1303 | 3.1 | 41.8 (40.9-42.9) | 52.5 (52.4-52.6) | 10.7 (9.7-11.7) |
| 30-34 | 14 | 1327 | 3.5 | 37.4 (36.5-38.5) | 47.8 (47.7-47.9) | 10.4 (9.4-11.4) |
| 35-39 | 36 | 1591 | 7.7 | 33.0 (32.2-34.0) | 43.1 (43.0-43.2) | 10.1 (9.2-11.0) |
| 40-44 | 45 | 1690 | 8.8 | 29.2 (28.4-30.2) | 38.4 (38.3-38.5) | 9.2 (8.3-10.1) |
| 45-49 | 62 | 1649 | 12.5 | 25.4 (24.6-26.3) | 33.8 (33.7-33.9) | 8.4 (7.5-9.3) |
| 50-54 | 59 | 1274 | 15.1 | 21.9 (21.1-22.8) | 29.3 (29.2-29.4) | 7.4 (6.5-8.3) |
| 55-59 | 60 | 902 | 21.0 | 18.4 (17.7-19.3) | 25.0 (24.9-25.0) | 6.6 (5.8-7.4) |
| 60-64 | 72 | 733 | 31.9 | 15.2 (14.5-16.0) | 20.8 (20.7-20.9) | 5.6 (4.8-6.4) |
| 65-69 | 57 | 378 | 45.3 | 12.4 (11.6-13.3) | 17.0 (16.9-17.0) | 4.6 (3.7-5.5) |
| 70-74 | 76 | 307 | 81.1 | 9.9 (9.2-10.7) | 13.5 (13.4-13.6) | 3.6 (2.8-4.4) |
| 75-79 | 44 | 167 | 82.4 | 8.8 (8.1-9.5) | 10.4 (10.4-10.5) | 1.6 (0.9-2.3) |
| ≥80 | 45 | 91 | 142.7 | 7.0 (6.5-7.7) | 7.8 (7.7-7.8) | 0.8 (0.1-1.5) |
| Women | ||||||
| 20-24 | 8 | 943 | 2.8 | 48.1 (46.9-49.3) | 61.0 (60.9-61.1) | 12.9 (11.7-14.1) |
| 25-29 | 7 | 1046 | 2.2 | 43.7 (42.7-44.8) | 56.1 (56.0-56.2) | 12.4 (11.3-13.5) |
| 30-34 | 13 | 1014 | 4.3 | 39.2 (38.1-40.3) | 51.2 (51.1-51.3) | 12.0 (10.9-13.1) |
| 35-39 | 19 | 1230 | 5.2 | 35.0 (33.9-36.0) | 46.3 (46.3-46.4) | 11.3 (10.2-12.4) |
| 40-44 | 25 | 1271 | 6.6 | 30.8 (29.8-31.8) | 41.6 (41.5-41.6) | 10.8 (9.8-11.8) |
| 45-49 | 39 | 1122 | 11.3 | 26.8 (25.8-27.7) | 36.8 (36.8-36.9) | 10.0 (9.0-11.1) |
| 50-54 | 41 | 939 | 14.4 | 23.2 (22.2-24.2) | 32.2 (32.1-32.3) | 9.0 (8.0-10.0) |
| 55-59 | 35 | 667 | 17.0 | 19.7 (18.8-20.6) | 27.7 (27.6-27.8) | 8.0 (7.1-8.9) |
| 60-64 | 40 | 540 | 24.2 | 16.3 (15.4-17.1) | 23.4 (23.3-23.5) | 7.1 (6.2-8.0) |
| 65-69 | 37 | 365 | 32.2 | 13.0 (12.3-13.7) | 19.3 (19.2-19.3) | 6.3 (5.6-7.0) |
| 70-74 | 57 | 286 | 64.1 | 9.8 (9.2-10.4) | 15.5 (15.4-15.5) | 5.7 (5.1-6.3) |
| 75-79 | 57 | 184 | 96.7 | 7.6 (7.1-8.1) | 12.0 (11.9-12.0) | 4.4 (3.9-4.9) |
| ≥80 | 73 | 127 | 171.3 | 5.8 (5.2-6.5) | 9.0 (8.9-9.0) | 3.2 (2.9-3.9) |
a
Additional life expectancy in years at each attained age interval conditional on survival until the start of that age interval with 95% confidence intervals.
b
This column gives the number of individuals in each sex and age stratum who attained the mid-age point for the interval during the study period 2008 through 2010.
c
General population after excluding those with type 1 diabetes.